Publication: Understanding the potential in vitro modes of action of bis(beta-diketonato) oxovanadium(IV) complexes
dc.contributor.coauthor | Xia, Ying | |
dc.contributor.coauthor | Waller, Zoe A. E. | |
dc.contributor.coauthor | Yıldızhan Yasemin | |
dc.contributor.coauthor | Lord, Rianne M. | |
dc.contributor.kuauthor | Sergi, Barış | |
dc.contributor.kuauthor | Bulut, İpek | |
dc.contributor.kuauthor | Ayhan, Ceyda Açılan | |
dc.contributor.kuprofile | PhD Student | |
dc.contributor.kuprofile | Master Student | |
dc.contributor.kuprofile | Faculty Member | |
dc.contributor.researchcenter | Koç University Research Center for Translational Medicine (KUTTAM) / Koç Üniversitesi Translasyonel Tıp Araştırma Merkezi (KUTTAM) | |
dc.contributor.schoolcollegeinstitute | Graduate School of Health Sciences | |
dc.contributor.schoolcollegeinstitute | School of Medicine | |
dc.contributor.yokid | N/A | |
dc.contributor.yokid | N/A | |
dc.contributor.yokid | 219658 | |
dc.date.accessioned | 2024-11-09T12:11:35Z | |
dc.date.issued | 2021 | |
dc.description.abstract | To understand the potential in vitro modes of action of bis(beta-diketonato) oxovanadium(IV) complexes, nine compounds of varying functionality have been screened using a range of biological techniques. The antiproliferative activity against a range of cancerous and normal cell lines has been determined, and show these complexes are particularly sensitive against the lung carcinoma cell line, A549. Annexin V (apoptosis) and Caspase-3/7 assays were studied to confirm these complexes induce programmed cell death. While gel electrophoresis was used to determine DNA cleavage activity and production of reactive oxygen species (ROS), the Comet assay was used to determine induced genomic DNA damage. Additionally, Forster resonance energy transfer (FRET)-based DNA melting and fluorescent intercalation displacement assays have been used to determine the interaction of the complexes with double strand (DS) DNA and to establish preferential DNA base-pair binding (AT versus GC). | |
dc.description.fulltext | YES | |
dc.description.indexedby | WoS | |
dc.description.indexedby | Scopus | |
dc.description.indexedby | PubMed | |
dc.description.issue | 15 | |
dc.description.openaccess | YES | |
dc.description.publisherscope | International | |
dc.description.sponsoredbyTubitakEu | N/A | |
dc.description.sponsorship | UKRI Future Leaders Fellowship | |
dc.description.version | Publisher version | |
dc.description.volume | 16 | |
dc.format | ||
dc.identifier.doi | 10.1002/cmdc.202100152 | |
dc.identifier.eissn | 1860-7187 | |
dc.identifier.embargo | NO | |
dc.identifier.filenameinventoryno | IR02949 | |
dc.identifier.issn | 1860-7179 | |
dc.identifier.link | https://doi.org/10.1002/cmdc.202100152 | |
dc.identifier.quartile | Q3 | |
dc.identifier.scopus | 2-s2.0-85106561205 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14288/1078 | |
dc.identifier.wos | 654746500001 | |
dc.keywords | Apoptosis | |
dc.keywords | Diketonate complexes | |
dc.keywords | Bioinorganic chemistry | |
dc.keywords | DNA interactions | |
dc.keywords | Vanadium complexes | |
dc.language | English | |
dc.publisher | Wiley | |
dc.relation.grantno | MR/T041315/1 | |
dc.relation.uri | http://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/9596 | |
dc.source | ChemMedChem | |
dc.subject | Medicinal chemistry | |
dc.subject | Pharmacology | |
dc.subject | Pharmacy | |
dc.title | Understanding the potential in vitro modes of action of bis(beta-diketonato) oxovanadium(IV) complexes | |
dc.type | Journal Article | |
dspace.entity.type | Publication | |
local.contributor.authorid | N/A | |
local.contributor.authorid | N/A | |
local.contributor.authorid | 0000-0002-8936-3267 | |
local.contributor.kuauthor | Sergi, Barış | |
local.contributor.kuauthor | Bulut, İpek | |
local.contributor.kuauthor | Ayhan, Ceyda Açılan |
Files
Original bundle
1 - 1 of 1